Senior insider sale
Chief Financial Officer at ESPERION THERAPEUTICS, INC. — senior position signals high conviction
$51.4K
17.20K shares
What this filing means
HALLADAY BENJAMIN plans to sell 17.20K shares of ESPERION THERAPEUTICS, INC. valued at approximately $51.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001959173-26-004747
Officer· Chief Financial Officer
Since Nov 2022
17.20K
Shares to sell
$51.4K
Approx. market value
10.77K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
6/15/2026
10.77KTotal acquired10.77K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/15/2026 | Restricted Stock Vesting Compensation | 10.77K | — |
| Total | 10.77K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.42K
Market value
$17.4K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
10.77K
Market value
$34.0K
6/17/2026
Total
Units
17.20K
Value
$51.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 6.42K | $17.4K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 10.77K | $34.0K | NASDAQ | Planned |
| Total | 17.20K | $51.4K | ||